Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    (L)-leucine

    ACTIVE PHARMA INGREDIENTS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4CABERGOLINE

    02 1LINZESS

    03 1MUPIROCIN

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ABBVIE
    U.S.A
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LINACLOTIDE

    Drug : LINZESS

    Dosage Form : CAPSULE; ORAL

    Application Number : 202811

    Country : US

    Patented : Yes

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ACTAVIS LABS FL INC

    Cabergoline

    PEGS Boston Summit
    Not Confirmed
    arrow

    03

    APOTEX CORP

    Cabergoline

    PEGS Boston Summit
    Not Confirmed
    arrow

    04

    GLENMARK PHARMS

    Mupirocin

    PEGS Boston Summit
    Not Confirmed
    arrow

    05

    IVAX SUB TEVA PHARMS

    Cabergoline

    PEGS Boston Summit
    Not Confirmed
    arrow

    06

    PHARMOBEDIENT

    Cabergoline

    PEGS Boston Summit
    Not Confirmed
    arrow
    PHARMOBEDIENT
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CABERGOLINE

    Drug : CABERGOLINE

    Dosage Form : TABLET; ORAL

    Application Number : 202947

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.